Tasly: Bortezomib for injection obtained the drug registration certificate.
() On the evening of September 6th, it was announced that Jiangsu Diyi, a wholly-owned subsidiary, had obtained the registration certificate of bortezomib for injection. Bortezomib, as one of the anti-tumor drugs, is used to treat multiple myeloma and mantle cell lymphoma.
Tasly subsidiary obtained the registration certificate of bortezomib for injection.
Tasly announced that recently, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. ("Jiangsu Diyi"), a wholly-owned subsidiary of the company, received the Pharmaceutical Registration Certificate on bortezomib for Injection approved and issued by National Medical Products Administration.
It is reported that bortezomib is a bispeptide borate analogue, and it is the world’s first artificially synthesized new competitive inhibitor of proteasome for clinical use. As one of the anti-tumor drugs, bortezomib is used for the treatment of multiple myeloma and mantle cell lymphoma.
According to the announcement, bortezomib for injection is another anti-tumor injection product that the company obtained the drug registration certificate after the approval of temozolomide for injection, which is regarded as passing the consistency evaluation, further enriching the company’s product pipeline. Jiangsu Diyi also produces bortezomib raw materials, which has advantages in effectively controlling production costs, and at the same time, the quality and supply of this variety of raw materials can be better guaranteed.
Zhao Huaizhi, the shareholder of Zhonggong Hi-Tech, reduced his holdings by 1.58%, and reduced his holdings by more than half.
() Announcement: As of September 5, 2022, Zhao Huaizhi, a shareholder of the company, reduced his holdings by a total of 1,052,500 shares through centralized bidding and block trading, accounting for 1.58% of the total shares of the company. More than half of his holdings have been reduced, and his shareholding ratio has dropped to 4.44%.
Kindick was notified of the approval of the supplementary application for "tetravalent influenza virus split vaccine"
Kindike announced that recently, the company received the Notice of Approval for Supplementary Drug Application issued by National Medical Products Administration (hereinafter referred to as "National Medical Products Administration"), and the name of the drug was tetravalent influenza virus split vaccine.
Kindick: Get the approval notice of the supplementary application for tetravalent influenza virus split vaccine.
Kindick announced on the evening of September 6 that he had obtained the approval notice for the supplementary application of tetravalent influenza virus split vaccine. This approval is conducive to expanding the market share of products.
Kindick: Notice of Approval for Supplementary Application for Tetravalent Influenza Virus Split Vaccine
On September 6, the financial sector announced that Kindick had obtained the approval notice for the supplementary application of tetravalent influenza virus split vaccine, including the expansion of the preparation scale.
An Kai bus and Foday battery set up a joint venture company to build a new energy power battery factory.
() Announce that, at the time of rapid development of global new energy industry, in order to meet market challenges, Company (Party D) and Anhui () Group Co., Ltd. ("Jianghuai Automobile", Party A), Foday Battery Co., Ltd. ("Foday Battery", Party B) and Zhejiang Storage Energy Group Co., Ltd. ("Zhejiang Storage Energy", Party C), on the basis of equality, voluntariness, mutual benefit and common interests.
Sifang plans to jointly invest and set up a joint venture company, which will build a new energy power battery factory (power battery factory) and carry out new energy power battery production projects with a production scale of 10GWh-20GWh. The products are mainly used in commercial vehicles and other markets. The production scope of the joint venture company includes but is not limited to phosphate cathode materials, layered transition metal oxide cathode materials and blade batteries based on the mixed systems of the above materials.
The registered capital of the joint venture company is RMB 1 billion, of which Party A plans to contribute RMB 200 million in cash, accounting for 20% of the registered capital of the joint venture company; Party B intends to invest in cash and other rights and interests at a fixed price, with a total investment of RMB 120 million (including cash investment of not less than RMB 50 million), accounting for 12% of the registered capital of the joint venture company; Party C intends to contribute RMB 230 million in cash, accounting for 23% of the registered capital of the joint venture company; Party D intends to contribute RMB 450 million in cash, accounting for 45% of the registered capital of the joint venture company.
The company said that the signing of the joint venture framework agreement aims to give full play to the advantages of all parties and achieve win-win cooperation and coordinated development in the field of new energy through complementary advantages and resources. At the same time, it is conducive to further enhancing the company’s competitiveness, laying a solid foundation for the company’s transformation business breakthrough, and has a positive impact on consolidating the company’s new energy business development.
Baiyun Airport: Passenger throughput in August increased by 52% year-on-year.
The financial sector announced on September 6th that there were 31,691 flights in August, up by 29.49% year-on-year. In August, the passenger throughput was 3,487,500, a year-on-year increase of 51.73%.
The controlling shareholders and concerted parties of Suli Co., Ltd. reduced their holdings of convertible bonds by 10% of the total issued amount.
() Announcement: On September 6, 2022, Miao Jinfeng, the controlling shareholder of the company, reduced 783,200 "Suli Convertible Bonds", accounting for 8.18% of the total issuance, and its concerted action person, Ningbo Meishan Bonded Port Gusheng Investment Co., Ltd. ("Gusheng Investment") reduced 174,000 "Suli Convertible Bonds", accounting for 1.82% of the total issuance. After the completion of this reduction, Miao Jinfeng holds 2,233,600 "Suli Convertible Bonds", accounting for 23.33% of the total issuance; Gusheng Investment holds 601,900 "Suli Convertible Bonds", accounting for 6.29% of the total issuance.
Li Hao, director and vice president of Gravitation Media, intends to reduce his holdings by no more than 100,800 shares.
() Announcement, Li Hao, the director and vice president of the company, plans to reduce his holdings by no more than 100,800 shares within six months after 15 trading days from the date of this announcement by means of centralized bidding or block trading and other laws and regulations, accounting for 0.038% of the total shares of the company.
A total of 68,000,200 shares of the employee stock ownership plan of Industrial Securities have been reduced.
Industrial Securities announced that during the period from September 3, 2018 to September 5, 2022, 47.669 million shares of the company held by the company’s first employee stock ownership plan were all reduced through centralized bidding transactions. During the period from September 1, 2020 to September 5, 2022, all the 20,331,200 shares of the company held by the company’s second employee stock ownership plan were reduced through centralized bidding. The company and Xingzheng Asset Management will complete the liquidation and income distribution of related assets according to the provisions of the employee stock ownership plan.
Xingfa Group: Signed a cooperation framework agreement with Xinya Process
The financial sector announced on September 6th that the company and () signed a cooperation framework agreement to jointly invest in the construction of electronic adhesive products, and the first phase of the construction of 30,000 tons/year electronic adhesive products.
Tianma technology set up a subsidiary in Hubei to expand its business
() Announcement: Based on the strategic layout of the whole industrial chain and the needs of business expansion, the company has invested abroad to establish a wholly-owned subsidiary, Hubei tianma technology Industrial Co., Ltd., with a total registered capital of 100 million yuan.
An Kai Bus: It is planned to jointly build a new energy power battery production factory with Jianghuai Automobile and others.
An Kai Bus announced on the evening of September 6th that the company had signed a joint venture framework agreement with Jianghuai Automobile, Foday Battery Co., Ltd. and Zhechu Energy Group Co., Ltd. on the cooperation of power batteries. Sifang plans to jointly invest and set up a joint venture company to build a new energy power battery production plant and carry out new energy power battery production projects. The production scale of this project is 10GWh-20GWh, and the products are mainly used in commercial vehicles and other markets. Jianghuai Automobile is the controlling shareholder of the company. The registered capital of the joint venture company is 1 billion yuan, and Jianghuai Automobile plans to contribute 200 million yuan in cash, accounting for 20%; An Kai Bus plans to contribute 450 million yuan in cash, accounting for 45%.
Xingfa Group and Xinya Process signed a cooperation framework agreement to jointly invest in the construction of electronic adhesive products.
Xingfa Group announced that on September 6, 2022, the company ("Party A") and () Process (Guangdong) Co., Ltd. ("Xinya Process" and "Party B") signed the Cooperation Framework Agreement in Yichang City, Hubei Province. Party A and Party B unanimously agree that a new legal entity (the "new company") will be established in Xiaoting District, Yichang City at the capital contribution of both parties or their affiliated companies. After the establishment, the new company will devote itself to the research, development, production and sales of electronic adhesive products. The registered capital of the new company is 50 million yuan, of which Party A holds 49% and Party B holds 51%. The new company plans to build electronic adhesive products in stages at one time, covering an area of 100 mu, including 30,000 tons/year of electronic adhesive products in the first phase.
As shown in the announcement, Xinya Process has been deeply involved in the related industries of electronic processes for many years, forming a high-security and low-cost product supply chain. The core product electronic glue has formed a dominant position in the field of consumer electronics, and is committed to expanding into new energy vehicles, photovoltaic power plants, energy storage battery systems, MiniLED and other fields.
It is reported that in order to promote the transformation, popularization and application of the new company’s scientific and technological achievements in the field of electronic adhesive technology, Party A and Party B will cooperate in all aspects of technology, and Party A will open scientific research centers including but not limited to Hubei Three Gorges Laboratory to Party B and the new company, and give priority to recommending outstanding scientific and technological achievements in related fields to the new company.
Xingfa Group: Signed a cooperation framework agreement with Xinya Process to build electronic adhesive products.
Xingfa Group announced on the evening of September 6 that the company signed the Cooperation Framework Agreement with Xinya Process. It is planned to set up a new legal entity in Xiaoting District, Yichang City, funded by both parties or their affiliated companies. After the establishment, the new company will devote itself to the research and development, production and sales of electronic adhesive products. The registered capital of the new company is 50 million yuan, and the company’s shareholding ratio is 49%. The new company plans to build electronic adhesive products in stages at one time, covering an area of 100 mu, including 30,000 tons/year of electronic adhesive products in the first phase.
An Kai Bus and Jianghuai Automobile signed a joint venture framework agreement to jointly invest in the establishment of a () power battery production plant.
On the evening of September 6th, An Kai Bus announced that it had reached a consensus with Anhui Jianghuai Automobile Group Co., Ltd. (hereinafter referred to as "Jianghuai Automobile"), Foday Battery Co., Ltd. (hereinafter referred to as "Foday Battery") and Zhejiang Storage Energy Group Co., Ltd. (hereinafter referred to as "Zhejiang Storage Energy") on the cooperation of power batteries and signed the Joint Venture Framework Agreement on September 6th.
Specifically, the Quartet plans to jointly invest in the establishment of a joint venture company, which will build a new energy power battery production plant and carry out new energy power battery production projects. The registered capital of the joint venture company is 1 billion yuan, of which Jianghuai Automobile plans to contribute 200 million yuan in cash, accounting for 20% of the registered capital of the joint venture company; Foday Battery plans to invest in cash and other rights and interests, with a total investment of 120 million yuan (including cash investment of not less than 50 million yuan), accounting for 12% of the registered capital of the joint venture company; Zhechu Energy plans to contribute 230 million yuan in cash, accounting for 23% of the registered capital of the joint venture company; An Kai Bus plans to contribute 450 million yuan in cash, accounting for 45% of the registered capital of the joint venture company.
An Kai Bus said that the signing of the joint venture framework agreement, the establishment of a joint venture company, the construction of a new energy power battery production plant and the development of new energy power battery production projects are aimed at giving full play to the advantages of all parties, and achieving win-win cooperation and coordinated development through complementary advantages and resources. At the same time, it is conducive to further enhancing the company’s competitiveness, laying a solid foundation for realizing the company’s transformation business breakthrough, having a positive impact on consolidating the company’s new energy business development, and meeting the company’s strategic development needs and the interests of all shareholders.
Zhang Maoyi, the actual controller of Jiansheng Group, reduced his shareholding by 4%.
() Announcement was issued. As of the disclosure date of this announcement, Mr. Zhang Maoyi, the controlling shareholder and actual controller, has reduced the company’s unrestricted shares by 15.25 million shares, accounting for 4.00% of the company’s total share capital. The implementation of this reduction plan has been completed.
Zhewen Film: It is planned to sell some properties of Century Changlong, a wholly-owned subsidiary.
() On the evening of September 6th, it was announced that the company planned to sell the office building of Century Changlong Film and Television Co., Ltd., a wholly-owned subsidiary, located in Building 12, Zone G, Gulou District Software Park, Fuzhou City, Fujian Province through Fujian Property Rights Exchange Center. The listing price was not lower than the estimated price of 33.3317 million yuan.
Zhewen Film intends to sell some properties of its subsidiary Century Changlong.
Zhewen Film announced that due to the streamlining of the business of Century Changlong, a wholly-owned subsidiary of the company, there is no need to use large-scale office buildings. In order to revitalize assets and promote cash return, the company plans to sell its office building located in Building 12, Zone G, Gulou Software Park, Fuzhou City, Fujian Province through Fujian Property Rights Exchange Center. The listing price is not lower than the evaluation price of 33,331,700 yuan, and the final transaction amount is subject to the public transaction results.
*ST Ronghua and relevant responsible persons received a warning letter from Gansu Securities Regulatory Bureau.
() Announcement: On September 6, 2022, the company received the Decision of Gansu Supervision Bureau of China Securities Regulatory Commission ("Gansu Securities Regulatory Bureau") on the Supervision and Management Measures of Gansu Ronghua Industrial (Group) Co., Ltd.. Liu Yong, Chairman and General Manager of the Company, and Li Qinghua, Director, Deputy General Manager and Chief Financial Officer, received the Decision on Taking Supervision and Management Measures of Issuing Warning Letters to Liu Yong and the Decision on Taking Supervision and Management Measures of Issuing Warning Letters to Li Qinghua from Gansu Securities Regulatory Bureau.
After investigation, the company failed to accurately estimate the provision for inventory depreciation and the estimated liabilities for illegal guarantee before the disclosure of the performance forecast on January 27, 2022, resulting in a difference of 69.4% between the forecast performance disclosed by the company and the actual performance, and failed to prompt the company that its net assets were negative in time, so the stock will be warned of relevant risks by delisting risk, which violates relevant regulations. As the company’s chairman and general manager, directors, deputy general manager and chief financial officer, Liu Yong and Li Qinghua failed to perform their duties faithfully and diligently, and were the main responsible persons for the above-mentioned violations of the company.
According to the relevant regulations, Gansu Securities Regulatory Bureau decided to take the supervision and management measures of issuing warning letters to the company, Liu Yong and Li Qinghua, and record them in the integrity files of the securities and futures markets.
Lushan New Materials granted 1.38 million restricted shares at a price of 33.36 yuan/share.
() Announcement: The conditions for granting restricted shares for the first time stipulated in "Guangzhou Lushan New Materials Co., Ltd. 2022 Restricted Stock Incentive Plan (Draft)" have been achieved. The company decided to take September 5, 2022 as the first grant date, and granted 1.38 million restricted shares to 51 eligible incentive targets for the first time at the grant price of 33.36 yuan/share.
Taiji Group: Levofloxacin and Sodium Chloride Injection was approved to increase the specification and supplement the approval.
() On the evening of September 6th, it was announced that Southwest Pharmaceutical Co., Ltd., a holding subsidiary, received the approval notice from National Medical Products Administration on the application for drug supplement of levofloxacin and sodium chloride injection, and the application was to increase the drug specifications.
There is a big difference between the performance forecast and the actual performance *ST Ronghua and related personnel received a warning letter from Gansu Securities Regulatory Bureau.
On the evening of September 6th, *ST Ronghua announced that the company, its chairman and general manager Liu Yong and its director, deputy general manager and chief financial officer Li Qinghua had recently received a warning letter from Gansu Securities Regulatory Bureau.
It is understood that *ST Ronghua did not accurately estimate the inventory depreciation reserve and the estimated liabilities for illegal guarantee before the performance forecast was disclosed on January 27, 2022, resulting in a difference of 69.4% between the forecast performance and the actual performance disclosed by *ST Ronghua, and did not promptly remind the net assets to be negative, and the stock will be warned of the risks related to delisting risk, which violates the first paragraph of Article 3 of the Measures for the Administration of Information Disclosure of Listed Companies (Order No.182 of the CSRC). Liu Yong and Li Qinghua, as the chairman and general manager, directors, deputy general managers and chief financial officers of *ST Ronghua, failed to perform their duties faithfully and diligently, and were the main responsible persons for the above-mentioned violations of *ST Ronghua.
Gansu Securities Regulatory Bureau said that according to the relevant provisions of the Measures for the Administration of Information Disclosure of Listed Companies, Gansu Securities Regulatory Bureau decided to take the supervision and management measures of issuing warning letters to companies, Liu Yong and Li Qinghua, and record them in the integrity files of the securities and futures markets.
Tasly lisinopril hydrochlorothiazide tablets "over-rated" for the treatment of hypertension.
On September 6th, Tasly announced that Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (hereinafter referred to as "Jiangsu Diyi"), a wholly-owned subsidiary of Tasly, received the Notice of Approval for Supplementary Application of Lisinopril Hydrochlorothiazide Tablets issued by National Medical Products Administration, and approved the drug to pass the consistency evaluation of generic drug quality and efficacy.
Lisinopril hydrochlorothiazide tablets are used to treat hypertension, and they are Class B varieties in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2021). The drug was accepted by CDE on August 2, 2021, and recently obtained the Notice of Approval for Supplementary Drug Application issued by National Medical Products Administration. Up to now, Jiangsu Diyi has invested 11,832,200 yuan in R&D for consistency evaluation of this drug. At present, there are two enterprises in the domestic market with the approval number of lisinopril hydrochlorothiazide tablets, and Tasly is the first enterprise to pass the consistency evaluation of this drug. According to the data of the chemical medicine medical terminal in Minenet, the annual sales of lisinopril hydrochlorothiazide tablets in domestic urban public, urban community, county-level public and township health departments in 2021 was 45.52 million yuan.
Hua ding shares: The General Administration of Market Supervision does not conduct further review on the case of True Love Group’s acquisition of company equity.
() Announcement: A few days ago, True Love Group Co., Ltd. ("True Love Group") has received the Decision of No Further Review for Centralized Anti-monopoly Review of Operators issued by the State Administration of Markets. The details are as follows:
"According to the provisions of Article 25 of the Anti-monopoly Law of the People’s Republic of China, after preliminary examination, it is decided that the case of True Love Group Co., Ltd. acquiring the equity of Yiwu Huading Nylon Co., Ltd. will not be further examined. Your company can implement centralization from now on. The case involves matters other than the centralized anti-monopoly review of operators and is handled in accordance with relevant laws. "
Wan Liyang: The holding subsidiary signed a strategic cooperation framework agreement with wan huitong Energy Company.
() On the evening of September 6th, it was announced that Zhejiang Wan Liyang Energy Technology Co., Ltd. (hereinafter referred to as "Wan Liyang Energy Company") and Wan () Technology Co., Ltd. (hereinafter referred to as "wan huitong Energy Company"), the holding subsidiaries of the company, signed a strategic cooperation framework agreement, and the two parties will carry out all-round strategic cooperation in power market operation management, green electricity operation management and carbon assets operation management of new energy power plants and pumped storage power plants for a period of five years.
Bohui Paper invested 860 million yuan to buy back shares, accounting for 6.04%.
() Announcement was issued. As of September 6, 2022, the company has bought back 80.77 million shares by centralized bidding, accounting for 6.04% of the company’s total share capital. The highest transaction price is 19.62 yuan/share, and the lowest transaction price is 6.70 yuan/share. The total amount paid is 860 million yuan (excluding transaction fees such as commission). This share repurchase is in compliance with laws and regulations and the company’s share repurchase plan.
Du Yulin, the controlling shareholder of Zhongwang Software, has accumulated 73,800 shares of the company.
Zhongwang Software announced that as of September 6, 2022, Mr. Du Yulin, the controlling shareholder, actual controller, chairman and general manager of the company, increased his holdings of 73,800 shares through the trading system of Shanghai Stock Exchange by centralized bidding, accounting for 0.085% of the total share capital of the company, and the total amount paid was RMB 10,690,500 (excluding transaction costs), which exceeded 50% of the lower limit of the planned increase. The implementation of this shareholding plan has not been completed, and Mr. Du Yulin will continue to increase the company’s shares in accordance with the relevant shareholding plan within the implementation time of the shareholding plan.
Wan Liyang subsidiary and wan huitong Energy Company reached a strategic cooperation on the operation of new energy-related power stations.
Wan Liyang announced that on September 6, 2022, Zhejiang Wan Liyang Energy Technology Co., Ltd. (referred to as "Wan Liyang Energy Company") and wan huitong Energy Technology Co., Ltd. (referred to as "wan huitong Energy Company"), a holding subsidiary of the company, signed the Strategic Cooperation Framework Agreement.
The two sides will carry out all-round strategic cooperation in power market operation management, green electricity operation management and carbon assets operation management of new energy power stations and pumped storage power stations, and the value-added benefits generated by the relevant projects of wan huitong Energy Company through the professional operation management services of Wan Liyang Energy Company will be enjoyed by both parties at 50% each.
According to the company, the signing of the strategic cooperation agreement will give full play to Wan Liyang Energy Company’s technical strength and rich experience in power market operation and management, green certificate and green electricity operation and management, and carbon asset operation and management, and provide professional services for the power stations under wan huitong Energy Company, which will help to further improve the operating efficiency of wan huitong Energy Company, and effectively enhance the profitability of Wan Liyang Energy Company through revenue sharing. At the same time, combined with the advantages of wan huitong Energy Company’s project resources, Wan Liyang Energy Company can further increase its market share in related business fields and continuously expand its business scale.
Qinghai Huading real controller acted in concert to create Dongfang Fidelity Investment to reduce its shareholding by 0.73%.
() Announcement was issued. On September 6, 2022, the company received the Notice on the Progress of the Share Reduction Plan from Shenzhen Chuangdongfang Fidelity Investment Enterprise (Limited Partnership) ("Chuangdongfang Fidelity"), which was the concerted action of the actual controller of the company. From September 2, 2022 to September 6, 2022, Chuangdongfang Fidelity reduced its shares by centralized bidding, accounting for 0.73% of the company’s total share capital.
The actual controller of Yongjin Co., Ltd. and its concerted parties reduced their holdings of "Yongjin Convertible Bonds" by 1,106,600.
() Announcement, the company received a notice from the controlling shareholder and actual controller, Mr. Yuji Qu (YUJIQUN), informing Mr. Yuji Qu (YUJIQUN), Ms. Cao Peifeng and their concerted actions, Ms. Cao Jingfen, Mr. Cao Wancheng and Mr. YUJASONCHEN (Yu Chenjie) to reduce their holdings of "Yongjin Convertible Bonds" by centralized trading in the Shanghai Stock Exchange system recently, accounting for 1,106,600.
Shanghai Pharmaceutical plans to set up a biomedical frontier industry innovation center with Zhangjiang Group and other 920 million yuan.
() Announcement: As one of the shareholder units, the company plans to jointly establish Shanghai Biomedical Frontier Industry Innovation Center Co., Ltd. ("Frontier Innovation Center") with Shanghai Overseas Co., Ltd. ("Shanghai Overseas"), Shanghai Second Medical Investment Management Co., Ltd. ("Second Medical Investment") and Shanghai Zhangjiang (Group ") with a registered capital of 9.20.
The announcement shows that Zhangjiang Group, as the main force in the construction of Zhangjiang Science City, the promoter of emerging industries, and the creator of science and technology, undertakes important functions such as development and construction, project introduction, industrial cultivation, functional services, and the creation of an innovative and entrepreneurial atmosphere. Second Medical Investment is a wholly-owned subsidiary of Shanghai Jiaotong University School of Medicine, which is responsible for foreign business and investment. Shanghai Jiao Tong University School of Medicine is a first-class medical school in China.
It is reported that the Frontier Innovation Center is positioned to carry out innovative research and development from new target discovery to phase II clinical research, gather the cutting-edge scientific research forces of "famous schools", "famous enterprises" and "famous hospitals" in Shanghai, adopt market-oriented operation mode, introduce high-end talents through various forms, closely follow the research and development process of new drugs from the discovery of lead compounds to the acquisition of candidate drug molecules, and then to clinical research (before phase II clinical research), and build a systematic, efficient, high-level and self-built system.
Jianghe Group’s subsidiary won the bid of 452 million yuan for the curtain wall subcontracting project of Huawei’s Shanghai Qingpu R&D and production project.
() Announcement: Beijing Jianghe Curtain Wall System Engineering Co., Ltd., a wholly-owned subsidiary of the company, recently received a bid-winning notice from Huawei Technologies Co., Ltd. for the curtain wall subcontracting project (bid 5) and (bid 6) of Huawei’s Shanghai Qingpu R&D and production project, with a total bid-winning amount of RMB 452 million, accounting for 2.17% of the company’s annual operating income in 2021.
The project is located in Qingpu District, Shanghai, with a total curtain wall area of about 243,700 square meters and an estimated total construction period of 381 days. After the project is completed, it will become an important research and development place for Huawei Technologies Co., Ltd..
Jiangxi-Guangdong Expressway: China Association of Interbank Market Dealers accepted the company’s registration and issued 4 billion yuan of ultra-short-term financing bonds.
() Announced that the company received the Notice of Acceptance of Registration from China Association of Interbank Market Dealers (Zhongshi Xiezhu [2022] SCP 324), and the association accepted the registration of the company’s ultra-short-term financing bonds, with the registered amount of the company’s ultra-short-term financing bonds being 4 billion yuan.
Jiaao Environmental Protection plans to invest in the first phase of the 1 million tons/year bio-jet fuel project, with an investment of about 4 billion yuan.
() Announced that the company signed the Project Cooperation Agreement with the Guanyun County People’s Government, and the company plans to invest in new biomass energy and new biomass materials projects in the Lingang Industrial Zone of Guanyun County.
The project plans to invest in new biomass energy and new biomass materials. The 1 million tons/year bio-jet coal project of new biomass energy project will be built in two phases, of which the first phase plans to invest about 4 billion yuan to build a 500,000 tons/year bio-jet coal project, which is scheduled to start construction in January 2023.
According to the announcement, the establishment of the company is based on the needs of the company’s future development strategy, which is conducive to the company’s reinforcement of the existing biodiesel industry chain, and can effectively promote the company to make full use of its own advantages to upgrade its products and expand the company’s profit space.
Xin ‘an shares: A performance briefing was held on September 5th.
On September 6, 2022 (), it was announced that the company held a performance briefing on September 5, 2022.
The details are as follows:
Q: Based on the product price announcement in the second quarter, the profit in the second quarter has not decreased much compared with the price drop. What caused the price to decrease and the profit didn’t decrease much?
A: Compared with the first quarter, the company’s product prices in the second quarter have declined, but at the same time, the prices of some raw materials (such as glycine) have dropped significantly compared with the first quarter, and the sales of some products (such as glyphosate raw materials and preparations) have also increased significantly compared with the first quarter. In addition, the optimization of product structure will also have a greater impact on the benefits. Therefore, there are many factors that affect profits, and the price of products is only one of them.
Q: How was the company’s operation in the third quarter? How is the inventory?
A: Please pay close attention to the company’s relevant announcements about the operating performance in the third quarter! As the third quarter has not yet ended, it is still too early to predict, but from the current market changes, the performance of the prices of major products in the industry, and the annual overhaul of the company’s equipment in September, it is expected that the second quarter may be in a weak trend. At present, the company’s inventory is in a normal state.
Q: The semi-annual report shows that the production and sales of two products in the company do not match, and the production is seriously greater than the sales. Is the product surplus or the product unsalable?
A: The output of the company’s original drugs, cyclic siloxanes, siloxane intermediates and metallic silicon products is seriously greater than the sales volume, which is mainly caused by the self-use of the upstream and downstream of the internal industrial chain, and there is no product surplus and unsalable sales.
Q: What is the current situation of the company’s glyphosate orders? What is the company’s judgment on the glyphosate boom in the next two years?
A: At present, the company has fully produced and sold glyphosate, and it has been scheduled for production in October. From the supply side, the new capacity of glyphosate industry will still be limited under the trend of supply-side reform and environmental protection normalization. With the gradual liberalization of domestic genetic modification, the relationship between supply and demand of glyphosate will be in a tight balance in the visible period. The demand side is affected by the outbreak of epidemic and geopolitics, and countries around the world put food security in a very important strategic position. With the rapid rise of global agricultural products prices, the global cultivated land area continues to increase, and farmers’ enthusiasm for planting has increased, which has brought support to the high prices of agricultural materials such as fertilizers and pesticides.
Q: What is the company’s silicone cost and gross profit per ton at present?
A: At present, the cost in silicone has indeed changed, especially with the price fluctuation of industrial silicon and methyl chloride, which has brought about some impacts, including ups and downs. The overall cost has not changed much. The basic products in silicone have been greatly affected by market price changes, but the profitability of end products and special monomers in silicone has remained relatively stable. Overall gross profit per ton benefits from a complete silicon-based industrial chain and relatively maintains the leading level in the industry.
Q: What is the production and operation status of the company now? Key silicone, is glyphosate fully produced and sold? The impact of changes in domestic and international environment on the company.
A: At present, the company’s production and operation are normal, and silicone and glyphosate are in a state of full production and sales except for normal annual maintenance. The company pays close attention to the domestic and international environment and market changes, and adjusts its business strategy in time according to market conditions to ensure the maximum benefit of the company.
Q: At present, the raw materials of glyphosate in the company, yellow phosphorus and glycine, have fallen sharply. What is the profit of glyphosate in the company now? What is the approximate cost per ton? How much will the depreciation of RMB against the US dollar bring to the company? Thank you.
A: The recent purchase price of glycine has indeed dropped significantly, but the purchase price of yellow phosphorus has obviously repeated recently after the previous decline. At present, the cost of glyphosate in the company remains relatively stable and the profitability is generally good. As the company mainly exports and mainly settles in US dollars, it did have a positive impact on the company’s operating performance at the moment when the RMB depreciated against the US dollar. By the end of half a year, the accumulated exchange gains and losses were about 40 million yuan.
Q: When will the 20,000-ton high-performance silicone material project in Xin ‘an Mai Tu, the 100,000-ton silicon powder in Xiexin Leshan, the first phase of western Xinyu pesticide, the 50-ton silicone rubber and 10-ton electronic potting adhesive in Qingyuan, Guangdong, the 30-ton photovoltaic adhesive, the flame retardant project in Xin ‘an, Fujian, the 30,000-ton photovoltaic adhesive project added by Lide and the Zijin Liyuan Ferrous lithium phosphate project all be put into production?
A: The 52,000-ton high-performance silicone material project in Xin ‘an Mai Tu has been put into production. The Xiexin Leshan silicon powder project will be completed and put into operation in the first half of 2023, and the first phase of the western Xinyu selective herbicide project will be put into operation at the end of this year. Xin’ an Tianyu new project is currently in the preliminary preparation process and has not yet started construction. The first phase of Fujian Xin ‘an Flame Retardant Project will be completed and put into operation in the middle of next year. Lide’s 30,000-ton photovoltaic rubber project has entered the stage of equipment procurement, and it is planned to be put into production at the end of this year and early next year. Zijin Lithium Yuan Ferrous lithium phosphate Project is scheduled to be completed and put into operation in the first half of next year.
Q: Please tell us about the company’s current production capacity and layout of industrial silicon, especially the Yunnan Yanjin project. Besides self-use, how much production capacity does the company currently sell to the outside world every month? Thank you.
A: The company’s current production capacity is mainly concentrated in Yunnan, Sichuan and Heilongjiang, with an existing production capacity of about 150,000 tons. The Yanjin project in Yunnan is still under construction. At present, the self-produced industrial silicon is mainly used for the production of silicone products for personal use.
Q: Are most of the equipment in the relocation project of the civilized industrial park of the company repurchased or reused? Does the government compensate for the relocation expenses incurred? What are the plans for the idle plots in the old park after the relocation? After the relocation, what is the difference between the new park and the old park in terms of production capacity?
A: Kaihua () Park is mainly for newly-built production capacity, and all facilities and equipment have been redesigned and constructed. The government will give some relocation compensation, and the land in the old park will be returned to the government after relocation. The new park plans a 300,000-ton special silicone material project, which greatly improves the original production capacity and varieties.
The main business of Xin ‘an Co., Ltd.: development, production and sales of high-efficiency and low-toxicity pesticide products such as glyphosate and chlorpyrifos; Development, production and operation of silicone monomer and its downstream products; Development, production and operation of fine and biochemical products and provision of transportation services.
The 2022 interim report of Xin ‘an Co., Ltd. shows that the company’s main income is 13.343 billion yuan, up 57.72% year-on-year; The net profit of returning to the mother was 2.334 billion yuan, up 181.69% year-on-year; Deducted non-net profit was 2.322 billion yuan, up 181.32% year-on-year; In the second quarter of 2022, the company’s main revenue in a single quarter was 6.841 billion yuan, up 46.98% year-on-year; The net profit returned to the mother in a single quarter was 1.108 billion yuan, up 102.28% year-on-year; Non-net profit deducted in a single quarter was 1.109 billion yuan, up 102.95% year-on-year; The debt ratio is 39.66%, the investment income is 71.8545 million yuan, the financial expenses are-34.7922 million yuan, and the gross profit margin is 27.02%.
In the last 90 days, the stock has been rated by 3 institutions and 3 buy ratings; The average institutional target price in the past 90 days is 30.2.
The following is the detailed profit forecast information:
The data of margin financing and securities lending show that the stock has a net inflow of 163 million in the past three months, and the financing balance has increased; The net inflow of securities lending was 12.5678 million, and the balance of securities lending increased. According to the financial report data in the past five years, the Securities Star valuation analysis tool shows that the moat of competitiveness in Xin ‘an stock industry is good, its profitability is good, and its revenue growth is average. Financial health. The stock has a good company index of 3.5 stars, a good price index of 3.5 stars and a comprehensive index of 3.5 stars. (The index is for reference only, and the index range is 0~5 stars, with a maximum of 5 stars)
Chengdu Pioneer: A performance briefing will be held on September 2nd.
On September 6, 2022, Chengdu Pioneer announced that the company held a performance briefing on September 2, 2022, and investors who participated in the company’s semi-annual performance briefing in 2022 participated through the online platform of "SSE Roadshow Center".
The details are as follows:
Q: Why did the company’s financial expenses change so much in the first half of the year?
A: Hello, thank you for your attention to the company! The decrease of the company’s financial expenses in the first half of the year is mainly due to the increase of exchange income caused by the change of foreign currency exchange rate in this period. Thank you!
Q: How was the domestic market development in the first half of the year?
A: Hello, thank you for your attention to the company! In view of the diversified needs of domestic customers, the company actively promotes various services related to new drug research and development and promotes the external transfer of self-developed new drug projects in combination with the company’s four core technology platforms and one-stop service capabilities for preclinical drug research and development. In the first half of the year, the income of domestic customers of the company was 28,355,800 yuan, a year-on-year increase of 25.42%, accounting for 20.44% of the operating income.
Q: What are the reasons for the performance changes in the first half of the year and what are the solutions?
A: Hello, thank you for your attention to the company! The main reasons for the performance changes in the first half of 2022 are as follows
1. The revenue of DEL customized library and screening service decreased year-on-year. DEL customized library service mainly provides customized DN-coded compound library design and synthesis services for global innovative pharmaceutical R&D and production enterprises (mainly large multinational pharmaceutical companies), helping the other party to provide early R&D basic platform construction. This type of business has the characteristics of large single order amount, long contract negotiation cycle and execution cycle. With the wide application of DEL technology, the company’s DEL screening service is in a period of upgrading and transformation. In addition to large multinational pharmaceutical companies, the customer base has gradually expanded to biotechnology companies, chemical companies, foundations and scientific research institutions. Different from large multinational pharmaceutical companies covering multiple targets under the same order, the overall order amount is large, and some small or start-up biotechnology companies or scientific research institutions may screen targets in a special field, covering fewer targets, and the single order amount is relatively small.
2. The gross profit margin of some businesses such as customized development services for new drugs decreased. Based on the new drug project, the company provides one-stop new drug customization service for domestic customers. This kind of business usually has a large contract order amount and a long execution period, and has the characteristics of early new drug project research and development, that is, the degree of customization is high, and the development difficulty, time period, cost and success rate of each stage of project implementation are different. During the reporting period, the customized development project of new drugs was still in the early research stage, and at the same time, it had different implementation stages and different development difficulties compared with the comparable period, so the gross profit margin decreased. In addition, affected by the rising unit price of raw materials, the gross profit margin of related businesses with a relatively large proportion of raw materials in the cost decreased to some extent during the reporting period.
At present, the company is actively taking various countermeasures, such as continuing the order of customized libraries for existing customers, adding small customized libraries or characteristic customized libraries and other business models suitable for a wider customer base, and launching OpenDEL? Related business supplements its vacancy in the small-scale DEL library customization business market. At the same time, the company is increasing the construction of business team to actively expand customers with DEL screening service needs for different target types.
Q: Is there any separation between the company’s self-research projects and customers’ projects? Will there be any intellectual property disputes in the future?
A: Hello, thank you for your attention to the company! Intellectual property related to drug structure is the core IP of innovative drugs. In order to ensure that there is no conflict of interest between the company’s new drug research and development projects and customer screening projects, the company strictly abides by the principles of target exclusion and molecular structure exclusion in its business model. The original ownership of the compound structure in the company’s drug discovery platform belongs to the company. After the effective emerging compounds are found in the screening service mode or the new drugs independently developed are promoted to a certain extent, the company transfers the intellectual property rights related to the compound structure or the development and commercialization rights to the customers by signing an authorization and transfer agreement with the customers.
First, the principle of target exclusion. The company accepts the client’s entrustment of screening projects on the basis of targets. Once the client determines a screening target, it will have a certain exclusion period (usually 3 years, which is subject to the contract). During the exclusion period, the company will not accept other clients’ entrustment of screening services for the same target, nor will it screen independent new drug projects for this target.
Second, the exclusive principle of molecular structure. By signing a transfer and authorization agreement with customers, the company permanently and exclusively transfers the intellectual property rights of molecular structure to customers. Even if the molecule shows good drug-forming properties to other targets in the subsequent research and development process, it cannot be transferred and developed because of the exclusive mechanism. The implementation of the two exclusive principles ensures that there is no conflict of interest between the company’s new drug R&D project and the customer screening project, and between the projects of different customers, thus gaining great trust and recognition from customers at home and abroad, enabling the company’s unique model of "new drug R&D service+rights transfer of new drug research projects" to be carried out smoothly and maintaining a good reputation in the international pharmaceutical industry. thank you
Q: What caused the change of net cash flow generated by the company’s operating activities in the first half of the year?
A: Hello, thank you for your attention to the company! The change of net cash flow generated by the company’s operating activities in the first half of the year was mainly caused by the decrease of sales income in the current period and the increase of cash paid for goods and services. thank you
Q: What is the difference between your company’s DEL technology and other companies’ DEL technology?
A: Hello, thank you for your attention to the company! Chengdu Pilot DEL technology has the following advantages and advantages.
First of all, the scale of molecular library that DEL library can achieve in design and synthesis has developed by leaps and bounds compared with the traditional one, which can reach trillions of solid molecular libraries (the number of traditional solid molecular libraries is generally in the millions);
Secondly, in terms of synthesis time and cost, using DEL library technology can build a large-scale molecular library resource with better diversity within a few years at a lower cost, while using traditional technology requires huge investment (about hundreds of millions of dollars) and years or even decades to accumulate;
Thirdly, because all the compounds have DN codes, it is possible to confirm the chemical structure from the huge mixture signal by DN sequencing, and hundreds of billions or even trillions of compounds can be screened in the mixture, which is more efficient than the traditional lead compound discovery method (the traditional screening can only achieve millions of molecular screening due to the limitation of cost and technology);
Fourthly, due to the introduction of DN tag, hundreds of billions of compounds can form a mixture for one-time screening, which makes the molecular dosage required for screening extremely small, so the relative cost is extremely small;
Fifth, compared with SBDD, CDD and virtual screening technology, DEL technology can quickly screen emerging compounds and find new molecules that may become drugs even in the face of new targets and targets that lack target structure information and/or ligand reference information, and has wide applicability; And because a large number of compounds can be screened each time, the screening results can provide a large number of experimental results data for these technologies and accelerate the development of such technologies;
Sixth, the number of academic papers related to DEL library chemistry published by Chengdu Pioneer is among the best, which reflects the company’s advanced nature and high quality in improving library chemistry and provides basic support for molecular diversity;
Seventh, by the end of the reporting period, the company has accumulated rich experience in screening more than 51 target types and hundreds of targets, and achieved a screening success rate of nearly 80% in project synthesis;
Eighth, the successful application of different molecular types in target screening, such as small molecular compound library, macrocyclic compound library, covalent compound library, protein degradation compound library, molecular fragment compound library, etc., has expanded the scope of molecular types and drug targets.
Moreover, Chengdu Pioneer is the only growing biotechnology company with internationally leading DEL technology and FBDD/SBDD technology in the field of drug discovery. At the same time, the company also has two emerging technology platforms, namely, the technology platform related to research and development of new nucleic acid drugs (STO) and the technology platform related to targeted protein degradation (TPD), which has formed obvious differentiated competitive advantages and technical barriers with other biotechnology companies and CRO companies in the field of drug discovery.
Q: The British company you bought is also losing money when you read the semi-annual report. Please, what is the reason?
A: Hello, thank you for your attention to the company! Vernalis’s main business model is customized development service of new drugs based on its FBDD/SBDD core technology. This kind of business usually has a large overall order amount and a long execution cycle, and the contract stipulates that it will be carried out in stages with the progress of project research and development. During this period, Vernalis will receive the service consideration paid by customers in FTE mode, and after reaching certain key conditions in each stage, it will correspondingly receive milestone income. For example, in 2021, Vernalis obtained the pre-clinical milestone fee from Servier. The rights and interests of new drug projects in this kind of contract belong to the customer, and at the same time, the uncertain risk of R&D failure is also borne by the customer. At the same time, Vernalis’s customers are mostly perennial partners. The company acquired Vernalis in order to obtain technical and commercial synergies from the group level, thus enhancing the overall room for subsequent growth. thank you
Q: The company’s DEL database building and DEL screening capabilities are well-known in the world, and this part of the business is mainly American customers. Will the company consider establishing a small R&D team and BD team in the United States to smoothly meet the needs of customers, rather than passively waiting because of the impact of the epidemic?
A: Hello, thank you for your advice! The company has established a subsidiary in the United States, Delaware, which is responsible for technology research and development and business development. According to the current and subsequent environmental situation, the company will consider whether to expand the R&D team and business team in the United States. thank you
Q: What is the current quantity and quality of DEL molecular library?
A: Hello, thank you for your attention to the company! By the end of the reporting period, the number of DEL library molecules of the company has exceeded 1.2 trillion, which is the largest and largest solid small molecule compound library in the world. At the same time, through the systematic design of library molecules, the company has added more than 6,000 kinds of synthetic molecular skeletons, basically covering the core skeletons of all small molecular drugs that have been approved for marketing at present, as well as most dominant skeletons of small molecular projects under clinical research, with nearly 40,000 kinds of synthetic building blocks.
Chengdu Pioneer’s main business: using its core technology DEL technology to provide research and development services in the early stage of drug discovery and transfer of new drug research and development projects.
Chengdu Pioneer 2022 reported that the company’s main income was 139 million yuan, down 10.01% year-on-year; The net profit of returning to the mother was-7,058,100 yuan, a year-on-year decrease of 134.17%; Deducting non-net profit-12.2615 million yuan, down 204.55% year-on-year; In the second quarter of 2022, the company’s main income in a single quarter was 66.2504 million yuan, down 22.03% year-on-year; The net profit returned to the mother in a single quarter was 30,400 yuan, down 99.8% year-on-year; Non-net profit deducted in a single quarter was-1,873,700 yuan, a year-on-year decrease of 121.12%; The debt ratio is 23.05%, the investment income is 9,645,500 yuan, the financial expenses are-10,596,200 yuan, and the gross profit margin is 37.15%.
In the last 90 days, the stock has been rated by 2 institutions and 2 buy ratings; The average institutional target price in the past 90 days was 18.9.
The following is the detailed profit forecast information:
The data of margin financing and securities lending shows that the net financing outflow of the stock in the past three months is 17.9925 million, and the financing balance is reduced; The net inflow of securities lending was 1,905,900, and the balance of securities lending increased. According to the financial report data in recent five years, the Securities Star valuation analysis tool shows that the moat of competitiveness in Chengdu’s leading industry is good, with good profitability and good revenue growth. There may be hidden troubles in finance, and the financial indicators that should be focused on include: accounts receivable/profit rate, the increase of accounts receivable/profit rate in the past three years, and operating cash flow/profit rate. The stock has a good company index of 3 stars, a good price index of 2 stars and a comprehensive index of 2.5 stars. (The index is for reference only, and the index range is 0~5 stars, with a maximum of 5 stars)
Semi-annual equity distribution of Shimao Energy: 0.2 yuan registered its equity on September 14th for each share.
() Announced that the company’s equity distribution in the first half of 2022 will be implemented: based on the company’s total share capital before the implementation of the plan, cash dividends will be distributed to each share, with 0.2 yuan (including tax), date of record on September 14th, 2022 and ex-dividend date on September 15th, 2022.
Mubang Hi-Tech plans to borrow 450 million yuan from the controlling shareholder.
On the evening of September 6th, () announced that the company intends to borrow money from Shantou Bangling Trading Co., Ltd. (hereinafter referred to as "Bangling Trading"), the loan amount does not exceed 450 million yuan, and the loan period is 12 months. Within this amount and period, the company can use it in a rolling way. The loan interest rate is not higher than the loan interest rate announced by the one-year commercial bank for the same period.
Mubang Hi-Tech said that this loan from Bangling Trade is to broaden the sources of funds and promote the construction and development of the company’s business, which is conducive to the company’s sustained and stable operation, in line with the interests of the company and all shareholders, and will not adversely affect the company’s future financial situation and operating results.
Ou Ke billion granted 310,000 restricted shares to the incentive object.
Ou Ke Billion announced that the company held a meeting on September 6, 2022, and deliberated and passed the Proposal on Granting Reserved Restricted Shares to Incentive Objects. It was determined that the reserved grant date of this incentive plan was September 6, 2022, and 310,000 restricted shares were granted to four eligible incentive objects at the grant price of 27.60 yuan per share.
Jiaao Environmental Protection: It is planned to invest 4 billion yuan to build a bio-jet fuel project with an annual output of 500,000 tons.
Jiaao Environmental Protection announced on the evening of September 6 that the company plans to implement a project with an annual output of 500,000 tons of bio-jet fuel in Lingang Industrial Zone, Guanyun County, Lianyungang City, and the project is scheduled to start construction in January 2023. The total planned investment of this project is 4 billion yuan, mainly from self-raised funds and financing. The products of the project are new biomass energy such as bio-jet fuel, and the raw materials are waste animal and vegetable oils. The production of this product has positive significance for reducing carbon emissions.
Botuo Bio’s two detection reagent products obtained the domestic medical device registration certificate.
Botuo Bio announced that two products of the company have recently obtained the People’s Republic of China (PRC) Medical Device Registration Certificate (in vitro diagnostic reagent) issued by the National Medical Products Administration (NMPA), namely "Detection reagent for histidine-rich protein II(HRP-II) of Plasmodium falciparum (colloidal gold method)" and "Detection reagent for NS1 antigen of dengue virus (colloidal gold method)".
City Investment Holdings: Vice Chairman Chen Shuai resigned.
() Announcement, the board of directors of the company recently received a written resignation report from Vice Chairman Chen Shuai. For personal reasons, Chen Shuai resigned from the board of directors as the vice chairman, director, member of the strategy committee and member of the remuneration and assessment committee of the 10th board of directors of the company.
Weiming Environmental Protection: Invest in high matte nickel projects and sign joint venture agreements.
() Announcement, Weiming (Hong Kong) International Holdings Co., Ltd., a wholly-owned subsidiary of the company, signed the Joint Venture Agreement on the Project of 50,000 Tons of Nickel-containing High-matte Nickel (Indonesia) with Merit, GEM Hong Kong and Weiming for investment in the construction of high-matte nickel project, with a total investment of no more than 448 million US dollars.
Baosteel packaging: Changxia Jinshi and its concerted actions reduced their holdings by 1.01%.
() Announcement was issued. On September 6, 2022, the company received the Letter of Notice on the Progress of Share Reduction issued by its shareholder Changxia Jinshi (Wuhan) Equity Investment Fund Partnership (Limited Partnership) and its concerted action partner Anhui Jiaokong Jinshi M&A Fund Partnership (Limited Partnership) ("Anhui Jiaokong Jinshi"). The above shareholders reduced their holdings by 11,427,500 shares this time, with a reduction ratio of 1.01%.
Sichuan Investment Energy: All power stations of Sichuan Investment Power are in good working condition.
The financial sector announced on September 6th that the dam surface of Renzonghai Reservoir of Tianwanhe Company was not damaged, and the generator sets of Renzonghai Power Station, Jinwo Power Station and Daji Power Station were not damaged. All power stations of Sichuan Investment Power are in good working condition, running safely and stably, and are doing their best to ensure power supply; The earthquake did not affect and cause losses to the construction of Panzhihua hydropower project, and the project safety was under control, and the project construction quickly returned to normal order.
Shenkeda: use the funds raised by "Shenke Convertible Bonds" to replace the self-raised funds that have been put into the fundraising projects in advance and paid the issuance fees.
On September 6, the financial sector announced that Shenkeda intends to use the funds raised by "Shenke Convertible Bonds" to replace the self-raised funds of 53,157,800 yuan that have been invested in fundraising projects in advance and paid the issuance fees. The replacement time of the company’s raised funds is less than 6 months from the time when the raised funds are received, which is in line with the requirements of relevant laws and regulations.
The GDR application of Guolian shares was accepted by China Securities Regulatory Commission.
() Announcement. Recently, the company received the Acceptance Form for Administrative License Application of China Securities Regulatory Commission (acceptance number: 222073) issued by China Securities Regulatory Commission (hereinafter referred to as "China Securities Regulatory Commission") on September 2, 2022, and the China Securities Regulatory Commission submitted to the company that the company intends to issue Global Depositary Receipts ("GDR") and list it on the Swiss Stock Exchange (hereinafter referred to as "GDR")
De Fengjie, shareholder of Haitai Xinguang, reduced his shareholding by 1.06%.
Haitai Xinguang announced that on September 6, 2022, the company received the Notice on Reducing Shares by More than 1% from the company’s shareholder Shanghai Defengjie Longsheng Venture Capital Partnership (Limited Partnership) (hereinafter referred to as "Defengjie") and its concerted parties, and the shareholder Defengjie reduced its shares by 923,000 shares, accounting for 1.0611% of the company’s total share capital.
Guisheng Co., Ltd. has no plans to engage in wine-related business, and the rumors about "liquor companies borrowing from the back door" are not true.
() It was announced that the company’s stock increased by 154.04% from July 13, 2022 to September 6, 2022, and the company’s stock price increased greatly in the short term. The company’s P/E ratio and P/B ratio have been significantly higher than the industry level.
As of the announcement date, the company’s production and operation are normal. The company is not involved in the negotiation or negotiation of "backdoor" and "reorganization" with wine enterprises, and has no plans to engage in wine-related business. The rumors about the company’s "backdoor" of wine enterprises are not true.
China grand auto: Bao Xiangyi succeeded Wang Xinming as president of the company.
() Announcement: Recently, the board of directors of the company received a written resignation application from Wang Xinming, the president of the company. Wang Xinming applied to resign as the president of the company for personal reasons, and his resignation report will take effect as of the date of delivery to the board of directors of the company. After resigning, Wang Xinming did not hold other positions in the company. In addition, on September 6, 2022, the board of directors of the company reviewed and approved the Proposal on Appointing the President of the Company and agreed to elect Bao Xiangyi as the President of the Company.
China grand auto set up brand division.
China grand auto announced that in order to actively build a management system that meets the requirements of the company’s development strategy, better integrate resources, optimize management efficiency and improve the company’s refined management level, the board of directors of the company reviewed and approved the Proposal on Adjusting the Company’s Organizational Structure on September 6, 2022. Based on the existing organizational structure of regional management, the company further strengthened brand management, set up a brand division and adjusted its internal organizational structure accordingly.
Weiming Environmental Protection plans to build a project with an annual output of 50,000 tons of nickel-bearing metal with high matte content in Indonesia together with Gemei Hong Kong.
Weiming Environmental Protection announced that on September 6, 2022, Weiming (Hong Kong) International Holdings Co., Ltd. ("Weiming Hong Kong Company" or "Weiming"), Merit International Capital Limited (hereinafter referred to as "Merit Company") and Gemei Hong Kong International Logistics Co., Ltd. (hereinafter referred to as "Gemei Hong Kong") signed the "About Merit, Gemei Hong Kong and High-matte Nickel Project"
It is reported that the company plans to establish a joint venture with Merit and Gemme Hong Kong. The tentative English name of the project company is PT JIAMANMEI NEW ENERGY, and the tentative Chinese name is Jiamanmei New Energy Co., Ltd.; Address: Jakarta, Indonesia. The authorized capital of the project company is US$ 1 million, with Weiming Hong Kong holding 51%, Merit holding 26% and GEM Hong Kong holding 23%.
According to the announcement, the high matte nickel project is planned to produce 50,000 tons of high matte nickel-containing metal annually, which is located in the Weda Bay Industrial Park (IWIP) in halmahera island, with a total investment of no more than 448 million US dollars. According to the company’s share ratio, the company’s investment in the project company this time with its own funds does not exceed 69 million US dollars. 30% of the total investment of the project shall be provided by the parties to the agreement with their own funds according to the proportion of their shares in the joint venture company, and 70% of the total investment of the project shall be financed by Weiming with the joint venture company as the borrower, and all parties to the agreement shall actively cooperate.
Zhongkong Zhilian: Announcement on Continued Suspension of Stock Trading
On September 6, 2022, Zhongkong Zhilian announced that due to the uncertainty of related matters, the company’s stock will continue to be suspended and it is expected to resume trading before September 9, 2022.
Financial Tips: According to public data, the operating income of Zhongkong Zhilian in 2021 was 1,148,058 yuan, the net profit attributable to the parent company was-585,056 yuan, the return on net assets was -10.07%, and the growth rate of operating income was null%. At present, the sponsoring brokerage firm is () Co., Ltd., and the trading method is call auction trading, which belongs to the basic level.
Saifutian has spent 32,270,300 yuan to repurchase 3,789,600 shares.
() Announcement was issued. As of August 31st, 2022, the company has repurchased 3,789,600 shares through centralized bidding, accounting for 1.32% of the company’s total share capital. The highest repurchase price is 10.00 yuan/share, and the lowest is 7.49 yuan/share, with a total transaction amount of 32,270,300 yuan (excluding transaction costs).
Weiming Environmental Protection: Signing a joint venture agreement to invest in high matte nickel projects.
Weiming Environmental Protection announced on the evening of September 6th that Weiming Hong Kong, a wholly-owned subsidiary of Weiming Hong Kong, signed a joint venture agreement with Merit Company and Gemei Hong Kong to invest in the construction of high matte nickel project with an annual output of 50,000 tons of nickel-containing metal (Indonesia). The company plans to invest and build a high matte nickel project through its subsidiaries, with an annual output of 50,000 tons of high matte nickel-containing metal, and the total investment of the project does not exceed 448 million US dollars. The company’s investment in the project company does not exceed USD 69 million.
Guolian shares: the application for issuing GDR was accepted by China Securities Regulatory Commission.
On the evening of September 6th, Guolian announced that the company’s application for issuing global depositary receipts (GDR) and listing on the Swiss Stock Exchange was accepted by the China Securities Regulatory Commission.
Hainan Rubber received compensation of 20.18 million yuan from rubber income insurance.
() Announcement, according to the Insurance Agreement of Hainan Rubber Income Insurance Project in 2021 signed by the company with China People’s Property Insurance Co., Ltd. and China Pacific Property Insurance Co., Ltd., the insurance compensation conditions were triggered by pests and diseases during April-May 2022, and the amount of insurance compensation was determined to be 20,181,100 yuan through three-party investigation and loss determination. Recently, the company has received the above compensation, and the accounting is included in other income.
Jinhong Gas and Zhongneng Silicon Industry reached a strategic cooperation on jointly promoting silane gas sales and other fields.
Jinhong Gas announced that based on the principles of equality, mutual benefit, resource sharing, complementary advantages and win-win cooperation, the company and Jiangsu Zhongneng Silicon Industry Technology Development Co., Ltd. ("Zhongneng Silicon Industry", GCL Photovoltaic Power Technology Holdings Co., Ltd. holds 64.16% and Fuduo International Development Co., Ltd. holds 35.84%) reached a strategic cooperation intention through friendly negotiation and recently signed the Strategic Cooperation Framework Agreement.
It is reported that the agreement is a strategic agreement reached by both parties through friendly negotiation, and does not involve specific content and amount. The two parties have established a strategic partnership, aiming at jointly promoting cooperation in silane gas sales and other fields through close cooperation and creating better economic and social benefits for both parties.
Leran Technology, the shareholder of Sirui New Materials, has increased its holdings by a total of 2,982,900 yuan, and the implementation of the increase has been completed.
Sirui New Materials announced that as of the disclosure date of this announcement, Shenzhen Leran Technology Development Co., Ltd. increased its holding of 257,600 shares by centralized bidding through the trading system of Shanghai Stock Exchange, accounting for 0.06% of the company’s total share capital, with a total holding amount of 2,982,900 yuan (including various taxes), and this holding plan has been implemented.
Jinhong Gas: Signed a strategic cooperation framework agreement with Zhongneng Silicon Industry.
Jinhong Gas announced on the evening of September 6 that the company signed a strategic cooperation framework agreement with Jiangsu Zhongneng Silicon Industry Technology Development Co., Ltd. to establish a strategic partnership on silane gas sales. Zhongneng Silicon Industry is responsible for producing and filling silane gas that meets the technical specifications and quality agreed by both parties, and the company purchases silane gas from it.
Two-board Vico technology: At present, there is no sodium battery related business in the company.
() Announcement of changes was issued. Recently, the company paid attention to the rumors about Vico Technology investing in sodium batteries in the market. In response to the rumors, the following explanations are made: the company’s main business has not changed, and the company does not have any sodium battery related business at present.
1,747,900 restricted shares of Sirui New Materials were listed and circulated on September 16th.
Sirui New Materials announced that the number of shares that the company lifted the restriction on sales and applied for listing and circulation was 1,747,900. Now the lock-up period is about to expire and it will be listed and circulated on September 16, 2022.
Wu Yongli, supervisor of power source, intends to reduce his holdings by no more than 105,700 shares.
Power source announced that due to personal capital demand, Mr. Wu Yongli, the supervisor, intends to reduce the company’s shares by no more than 105,700 shares by centralized bidding, accounting for 0.02% of the company’s total share capital.
*ST Garden City once again postponed the reply to the supervisory inquiry letter of the Shanghai Stock Exchange on the company’s 2021 annual report.
On the evening of September 6th, () announced that some issues involved in the Inquiry Letter on Information Disclosure Supervision of Yantai Yuancheng Gold Co., Ltd. 2021 Annual Report (hereinafter referred to as "Inquiry Letter on Supervision") still need to be further supplemented and improved, and the company is not expected to complete the reply within the specified time, so the company will postpone the reply for another five trading days to coordinate and promote the completion of the reply, and fulfill its information disclosure obligations in a timely manner as required.
It is understood that *ST Garden City received the "Regulatory Inquiry Letter" issued by the Management Department II of listed companies on the Shanghai Stock Exchange on April 22, requiring the company to reply within 5 trading days. It has been more than 4 months since then, and after more than ten delays, *ST Garden City has still failed to reply.
There is no sodium battery related business in Vico Technology at present.
Vico Technology announced that the closing price of the company’s shares deviated by more than 20% in three consecutive trading days on September 2, September 5 and September 6. According to the relevant provisions of the Trading Rules of Shanghai Stock Exchange, the company’s stock trading is in an abnormal fluctuation situation.
Recently, the company paid attention to the rumors that Vico Technology invested in sodium batteries in the market. In response to the rumors, it is now explained as follows: the company’s main business has not changed, and there is no sodium battery related business in the company at present.
Confirmed by the company’s self-examination and consultation with the controlling shareholder and actual controller: As of the disclosure date of this announcement, there are no significant matters or information that should be disclosed but not disclosed by the company, controlling shareholder and actual controller.
Jianlong Weina donated 500,000 yuan to Sichuan earthquake-stricken area.
Jianlong Weina announced that the company donated 500,000 yuan to Sichuan earthquake-stricken area through Luoyang Charity Federation for earthquake emergency rescue, transitional resettlement and post-disaster reconstruction.
Xingfa Group: It is planned to invest in electronic adhesive products with Xinya Process.
Xingfa Group announced that the company signed a cooperation framework agreement with Xinya Process, and both parties will invest to set up a new company in Xiaoting District, Yichang City. After the establishment of the new company, it will devote itself to the research, development, production and sales of electronic adhesive products, and build 30,000 tons/year of electronic adhesive products in the first phase.
Anhui Venture Capital, the shareholder of Wanyi Technology, plans to reduce its holdings by no more than 1,337,700 shares.
Wanyi Technology announced that the company received the Notice Letter on the Stock Reduction Plan issued by Anhui Venture Capital on September 6, 2022, and Anhui Venture Capital reduced the number of shares held by the company by centralized bidding from September 29, 2022 to December 31, 2022, with a reduction ratio of no more than 1,337,700 shares.
Zhewen Film Industry: It is planned to list some properties of its subsidiaries for sale.
Zhewen Film announced that the company intends to sell the office building of Century Changlong, a wholly-owned subsidiary, located in Building 12, Zone G, Gulou District Software Park, Fuzhou City, Fujian Province, at a listing price of not less than 33,331,700 yuan. If the above assets are sold at the listing price, the transaction is expected to affect the net profit attributable to shareholders of the listed company by about 15 million yuan.
Xinqianglian and Mingyang Intelligent reached a strategic cooperation in the fields of bearing design and development of new fans.
() Announcement: Recently, the company and Mingyang Smart Energy Group Co., Ltd. (() ",601615.SH) signed the Strategic Cooperation Framework Agreement. Through close cooperation between the two parties, we will build a win-win and sustainable strategic partnership and jointly promote all-round cooperation in the design and development of main shaft bearings and yaw pitch bearings of new wind turbines and the development and application of new technologies.
Xinqianglian: Signing a strategic cooperation framework agreement with Mingyang Intelligent.
Xinqianglian announced on the evening of September 6 that the company signed a strategic cooperation framework agreement with Mingyang Intelligent to jointly promote the comprehensive cooperation between the two sides in the design and development of main shaft bearings and yaw pitch bearings of new wind turbines and the development and application of new technologies.
Wanyi Technology: Anhui Venture Capital intends to reduce its shareholding by no more than 1%.
Wanyi Technology announced on the evening of September 6 that Anhui Venture Capital, a shareholder holding 5.53%, intends to reduce its shareholding by no more than 1%.
Delong Laser intends to subscribe for fund shares to invest in new materials, high-end equipment, digital technology and other industries.
Delong Laser announced that the company plans to invest 30 million yuan with its own funds to subscribe for 4.8687% of the subscribed capital of Suzhou Woyan Green Specialization Venture Capital Partnership (Limited Partnership) ("Suzhou Woyan"). After the completion of this round of fundraising, the total subscribed capital of Suzhou Woyan is 616.18 million yuan. Suzhou Woyan focuses on investing in high-quality unlisted growth enterprises in new materials, high-end equipment and digital technology-related industries.
() 20.41 million restricted shares were granted to the incentive object for the first time at a grant price of 6.95 yuan/share.
Ningbo Yunsheng announced that the company held the 12th meeting of the 10th Board of Directors on September 6th, 2022, and deliberated and passed the Proposal on Granting Restricted Stock to the Incentives of the Restricted Stock Incentive Plan in 2022 for the first time. According to the authorization of the second extraordinary shareholders’ meeting in 2022, the board of directors of the company considered that the conditions for the first grant of the restricted stock incentive plan in 2022 had been achieved, and agreed to set September 6th, 2022 as the first grant date to eligible 2022.
Jiaao Environmental Protection: It is planned to invest in new biomass energy and new biomass materials projects.
Jiaao Environmental Protection Announcement, the company plans to sign the Project Cooperation Agreement with Guanyun County Government, and the company plans to invest in new biomass energy and new biomass materials projects in the Lingang Industrial Zone of Guanyun County. The new biomass energy project with a capacity of 1 million tons/year of bio-jet coal will be built in two phases, of which the first phase plans to invest about 4 billion yuan to build a 500,000-ton/year bio-jet coal project, which is scheduled to start construction in January 2023.
Weiming Environmental Protection: It is planned to jointly invest in a project with an annual output of 50,000 tons of nickel-bearing metal with high matte content.
Weiming Environmental Protection announced that Weiming Hong Kong Company, a wholly-owned subsidiary of the company, signed a joint venture agreement with Merit Company and GEM Hong Kong to produce 50,000 tons of nickel-containing metal with high matte annually (Indonesia). The company plans to set up a joint venture with Merit Company and GEM Hong Kong to build a project company with an annual output of 50,000 tons of nickel-containing metal with a total investment of no more than 448 million US dollars. This time, the company’s investment in the project company with its own funds does not exceed USD 69 million.
Liu Kuanqing, a shareholder of Huatong Cable, plans to reduce its shareholding by no more than 3%.
() Announcement: Due to shareholders’ own capital needs, Liu Kuanqing, Zhang Huizhi, Ningbo Zeliantong and Ningbo Zewang intend to reduce their shares in the company by centralized bidding within three months after 15 trading days from the date of the announcement of the company’s reduction plan, with a total reduction of no more than 5,068,200 shares and a total reduction of no more than 1.00% of the company’s total share capital, and a total reduction of no more than 10,136,400 shares by block trading.
Tianqi Co., Ltd. and Jinghe Shaanxi Coal Research Institute reached a strategic cooperation to lock in the raw material resources of waste lithium batteries.
() Announcement: Recently, the company signed the Strategic Cooperation Framework Agreement with New Energy Materials Co., Ltd. of Jinghe New City Shaanxi Coal Technology Research Institute ("Jinghe Shaanxi Coal Research Institute"), and the two parties intend to cooperate in the field of lithium-ion battery core materials, waste power batteries and battery waste recycling, and jointly build a closed-loop industrial chain for recycling waste power batteries.
It is reported that Jinghe Shaanxi Coal Research Institute is a wholly-owned subsidiary of Shaanxi Coal Chemical Technology Research Institute ("Shaanxi Coal Research Institute"), a wholly-owned subsidiary of () Chemical Group Co., Ltd. ("Shaanxi Coal Group"). It is planned to be a research and development, test and demonstration production base for Shaanxi Coal Research Institute to realize industrialization in China with advanced technologies in the direction of independent innovation of new energy materials. The planned main products and businesses cover nickel ternary precursor materials, lithium phosphate precursors and their cathode materials, etc.
The announcement shows that this cooperation will help the company to further lock in the raw material resources of waste lithium batteries, provide continuous and stable raw material guarantee for the company’s lithium battery recycling business, and further strengthen the core competitiveness of the company’s lithium battery recycling business. In addition, based on the friendly cooperation between the two parties, the company and Jinghe Shaanxi Coal Research Institute will further jointly build a ternary precursor production line.
Huatong Cable: Shareholders intend to reduce their holdings by no more than 3% in total.
Huatong Cable announced on the evening of September 6th that the company’s shareholder Liu Kuanqing and his concerted action Zhang Huizhi, Zeliantong Equity Investment Partnership (Limited Partnership) in Ningbo Meishan Bonded Port Area and Zewang Equity Investment Partnership (Limited Partnership) in Ningbo Meishan Bonded Port Area intend to reduce their shares by no more than 3% of the company’s total share capital.
Huayang new materials: 60,000 tons/year PBAT project of new materials was successfully put into commissioning.
() On the evening of September 6th, it was announced that the 60,000-ton/year PBAT project began to feed the polymerization unit on September 3rd. At present, the project has been successfully put into trial operation at one time, and qualified products have been produced.
Huayang New Materials elected Wu Yuehua as the chairman.
Huayang New Materials announced that on September 6, 2022, the board of directors of the company reviewed and approved the Proposal on Electing the Chairman of the Seventh Board of Directors of the Company, and elected Wu Yuehua as the Chairman of the Seventh Board of Directors of the Company. It is reported that Wu Yuehua is currently a member of the Standing Committee and Director of the Party Committee of Taiyuan Chemical Industry Group Co., Ltd.; Party secretary, director and general manager of the company.
Huayang New Materials: The "60,000 tons/year PBAT Project of New Materials" was successfully put into trial operation at one time.
Huayang New Materials announced that since the company’s new material 60,000 tons/year PBAT project started construction last year, the company and the construction party overcame the epidemic situation and completed the installation and commissioning on August 10 this year. On August 22, the heat medium device started to heat up for thermal commissioning, and on September 3, it began to feed the polymerization device. At present, the project has been successfully put into trial operation at one time and produced qualified products.
The three shareholders of Zhengyuan intend to reduce their holdings by no more than 1.90% in total.
() It is announced that Hainan Furuiyuan, Hainan Happiness Health and Hainan Happiness Bio plan to reduce their holdings of the company by centralized bidding or block trading, with a total planned reduction of no more than 28.7 million shares, accounting for no more than 1.90% of the company’s total share capital.
Xinqianglian and Mingyang Intelligent signed a strategic cooperation framework agreement.
Xinqianglian announced that the company and Mingyang Smart Energy Group Co., Ltd. recently signed the Strategic Cooperation Framework Agreement. Through close cooperation between the two parties, we will build a win-win and sustainable strategic partnership and jointly promote comprehensive cooperation between the two parties in the design and development of main shaft bearings and yaw pitch bearings of new wind turbines and the development and application of new technologies.
Zhengyuan shares: the concerted action of the controlling shareholder intends to reduce its shareholding by no more than 1.9%.
Zhengyuan announced on the evening of September 6th that the concerted actions of Hainan Furuiyuan, Hainan Happiness Health and Hainan Happiness Bio, the controlling shareholders of the company, plan to reduce their holdings of the company’s shares by no more than 28,700,500 shares through centralized bidding or block trading, accounting for no more than 1.9% of the company’s total share capital.
Vico Technology: At present, there is no sodium battery related business in the company.
Vico Technology released a stock trading announcement. Recently, the company paid attention to rumors about Vico Technology’s investment in sodium batteries in the market. In response to the rumors, the following explanations are made: the company’s main business has not changed, and the company does not have any sodium battery related business at present.
Jinhong Gas signed a strategic cooperation framework agreement with Zhongneng Silicon Industry.
Jinhong Gas announced that the company signed a strategic cooperation framework agreement with Jiangsu Zhongneng Silicon Industry Technology Development Co., Ltd. (hereinafter referred to as "Zhongneng Silicon Industry"), and Zhongneng Silicon Industry was responsible for producing and filling silane gas that met the technical specifications and quality agreed by both parties; The company purchased silane gas from Zhongneng Silicon Industry.
The shareholders of Huatong Cable intend to reduce their holdings by no more than 3% in total.
Huatong Cable announced that Liu Kuanqing, Zhang Huizhi, Ningbo Zeliantong and Ningbo Zewang intend to reduce their shares by centralized bidding to no more than 1% of the company’s total share capital and by block trading to no more than 2% of the company’s total share capital within 3 months after the announcement of the company’s disclosure of the reduction plan.
Ruikeda’s shareholder, Guoke Ruihua, reduced its shareholding by 2.16% and its shareholding fell below 5%.
Ruikeda announced that as of September 6, 2022, Beijing Guoke Ruihua Strategic Emerging Industry Investment Fund (Limited Partnership) ("Guoke Ruihua"), a shareholder of the company, had reduced its shareholding by 2,336,100 shares, accounting for 2.1631% of the company’s total share capital, and the number of reductions had exceeded half. In addition, on September 6, 2022, Guoke Ruihua reduced its holdings by 1,090,100 shares, and after the reduction, it held 5,399,900 shares of the company, accounting for 49,999% of the total shares of the company.
Rejing Bio plans to buy back 150 million yuan to 300 million yuan, and the repurchase price does not exceed 98.11 yuan/share.
Rejing Bio announced that the company intends to buy back the RMB ordinary shares (A shares) issued by the company through centralized competitive bidding. The total amount of funds for repurchasing shares is not less than 150 million yuan (inclusive) and not more than 300 million yuan (inclusive), and the price of repurchasing shares is not more than 98.11 yuan/share (inclusive). The time limit for repurchasing shares is within 12 months from the date when the board of directors deliberates and passes this share repurchase plan.
The controlling shareholder of Zhengyuan Co., Ltd. intends to reduce its holdings by no more than 1.9% in total.
Zhengyuan shares announced that Hainan Furuiyuan, Hainan Happiness Health and Hainan Happiness Bio, the concerted actions of the company’s controlling shareholders, intend to reduce their shares by no more than 1.90% of the company’s total share capital.
Hot View Bio: It is planned to buy back shares of RMB 150 million to RMB 300 million.
Hot View Bio announced on the evening of September 6 that it plans to buy back its shares at a price of 150-300 million yuan, with the repurchase price not exceeding 98.11 yuan/share. The repurchased shares are intended to be used for employee stock ownership plans or equity incentives at an appropriate time in the future.
Two testing products of Hot Scenery Bio have obtained relevant certification in the UK.
On September 6, Hot Scenery Bio announced that its two testing products independently developed have obtained relevant certifications. Among them, the monkeypox virus antigen detection kit (colloidal gold method) was certified by MHRA in Britain for the detection of monkeypox virus antigen; Novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) has been certified by CTDA in the UK, which is used for rapid and qualitative detection of novel coronavirus antigen in human nasal swab in vitro. The product can be used for self-inspection by non-professionals.
Hot View Bio said that the monkeypox virus antigen detection kit (colloidal gold method) independently developed by the company can be sold in the UK and countries and regions that recognize the MHRA registration in the UK after being registered in the UK. The company’s novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) has obtained the British CTDA certification, and the Coronavirus Test Device Approvals (CTDA) is a regulation issued by the British government for COVID-19 detection reagents. The novel coronavirus (2019-nCoV) antigen test kit (colloidal gold method) obtained the five-year CTDA certification in the UK, which indicates that the company’s COVID-19 antigen test reagent has been fully recognized in the UK, and the authorization has been changed from emergency use to long-term certification, which will further serve the normal epidemic prevention needs in Covid-19, UK.
Fosun Industrial Investment, the concerted action of Hainan Mining’s controlling shareholder, reduced its shareholding by 1.66%.
() Announcement was issued. On September 6, 2022, the company received the Notice of Share Reduction from Shanghai Fosun Industrial Investment Co., Ltd. ("Fosun Investment"), the concerted action of the company’s controlling shareholder. From September 1, 2022 to September 6, 2022, Fosun Investment reduced its shareholding by 33.708 million shares, accounting for 1.66% of the company’s total share capital. As of the disclosure date of this announcement, Fosun Investment Co., Ltd. has reduced its holdings by more than half, and this reduction plan has not yet been implemented. Shanghai Fosun High-Tech (Group) Co., Ltd. is the controlling shareholder of Fosun Investment.
Chuantou Energy: Tianwanhe Company, a subsidiary company, will conduct investigation and repair in an orderly manner without any casualties.
Sichuan Investment Energy announced on the evening of September 6 that after the earthquake of magnitude 6.8 occurred in Luding County, Ganzi Prefecture, Sichuan Province, the company immediately launched an emergency plan and conducted a comprehensive investigation. The cascade power stations of Tianwanhe Company, a subsidiary of the company, are located in Kangding County, Ganzi Prefecture and Shimian County, Ya ‘an City, both of which belong to the Xianshuihe fault zone, and the nearest linear distance from the epicenter is only about 22 kilometers. After the earthquake, Tianwanhe Company immediately launched the first-class emergency response to emergencies, implemented scientific disaster relief to prevent secondary disasters and resumed work in an orderly manner under the condition of ensuring safety. At present, a total of 69 people have been evacuated to safety, and there are no casualties; Through Chengdu remote control production monitoring camera and on-site drone search, it is found that there are no signs of damage on the dam surface of Renzonghai Reservoir. The generator sets of Renzonghai Power Station, Jinwo Power Station and Daji Power Station were not damaged. However, due to the earthquake, the surrounding mountains and many travel sections collapsed, causing traffic disruption.
In the next step, Tianwanhe Company will, on the premise of ensuring the safety of personnel, carry out the investigation of hidden dangers of production equipment and hydraulic structures after the earthquake, the repair of equipment and facilities, the repair and reinforcement of damaged output lines and the rush of roads in an orderly manner, and strive to achieve comprehensive resumption of production as soon as possible and restore the safe and stable operation of river basin units.
A total of five hydropower stations in Qingyijiang, Tianquan River and Nirihe River basins, which belong to Sichuan Investment Power, a subsidiary of the company, are all about 100 kilometers away from the epicenter, and the earthquake was obvious at the scene. After the earthquake, each power station immediately entered an emergency state and launched emergency plans for emergencies and earthquakes, and conducted hidden dangers investigation on important points such as main power houses, unit equipment, dams and transmission lines. At present, the equipment of each power station is in good working condition, running safely and stably, and is doing its best to ensure power supply.
After on-site emergency safety inspection, the earthquake did not affect and lose the construction of Panzhihua hydropower project, a subsidiary of the company, and the project safety was under control, and the project construction quickly returned to normal order.
Shimao Energy will send 2 yuan date of record for every 10 shares in the first half of 2022 as September 14th.
Shimao Energy announced that the company’s half-year equity distribution implementation plan for 2022 is as follows: based on the total share capital of 160 million shares, a cash dividend of RMB 2.00 will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 32 million will be distributed, accounting for 33.45% of the net profit attributable to the mother in the same period. No bonus shares will be distributed and no capital reserve will be converted into share capital.
The distribution of rights and interests in date of record is September 14th, and the ex-dividend date is September 15th.
According to Shimao Energy’s semi-annual performance report for 2022, the company’s operating income was 201 million yuan, a year-on-year increase of 9.32%; The net profit attributable to shareholders of listed companies was 95.674 million yuan, a year-on-year increase of 14.77%; The basic earnings per share was 0.60 yuan, compared with 0.69 yuan in the same period last year.
The main business of Ningbo Shimao Energy Co., Ltd. is to produce and sell power and steam products. The company’s main products are steam and electricity, which are energy products based on industrial enterprises. Among them, steam products are supplied to industrial enterprises in Yuyao Zhongyi Ningbo Ecological Park, electroplating park and food park around the company, and all power products are incorporated into Ningbo power grid according to the Purchase and Sale Contract signed with Ningbo Power Supply Company of State Grid Zhejiang Electric Power Co., Ltd.
(Source: () iFinD)
Kanglongda: It is planned to acquire 17.67% equity of Tiancheng Lithium Industry for 212 million yuan.
() On the evening of September 6th, it was announced that the company planned to acquire 11.31% and 6.36% shares of Jiangxi Tiancheng Lithium Industry Co., Ltd. (referred to as "Tiancheng Lithium Industry") from Tiancheng Management and Yiyuan Lithium respectively for 212 million yuan, totaling 17.67% shares. After the transaction is completed, the company will hold 51% equity of Tiancheng Lithium Industry, and Tiancheng Lithium Industry will become a holding subsidiary of the company. The production line of 10,000 tons of lithium carbonate equivalent lithium sulfate solution in Tiancheng Lithium Industry has been completed, and it entered the trial production stage in May, and now it has reached the design capacity.
Kanglongda: It is planned to acquire 17.67% equity of Jiangxi Tiancheng Lithium Industry Co., Ltd. for 212 million yuan.
Kanglongda announced that on September 6, 2022, the company signed the Equity Transfer Agreement with Tiancheng Management, Yiyuan Lithium, Dong Aihua and Li Jinping, and planned to acquire 11.31% and 6.36% equity of Tiancheng Lithium from Tiancheng Management and Yiyuan Lithium respectively for 212 million yuan, totaling 17.67% equity. Before the completion of this transaction, Tiancheng Lithium Industry was a shareholding company holding 33.33% of the company’s shares; After the completion of this transaction, the company will hold 51.00% equity of Tiancheng Lithium Industry, and Tiancheng Lithium Industry will become a holding subsidiary of the company.
Kanglongda intends to increase its holdings in Tiancheng Lithium Industry and its existing production line of lithium sulfate solution with 10,000 tons of lithium carbonate equivalent.
Kanglongda announced that on September 6, 2022, the company signed the Equity Transfer Agreement with Yichun Propylene Tiancheng Management Consulting Center (Limited Partnership) ("Tiancheng Management"), Yichun Yiyuan Lithium Consulting Center (Limited Partnership) ("Yiyuan Lithium"), Dong Aihua and Li Jinping, and acquired Jiangxi Tiancheng Lithium Industry Co., Ltd. ("Tiancheng Lithium Industry") from Tiancheng Management and Yiyuan Lithium for 212 million yuan. After the completion of this transaction, the company will hold 51% equity of Tiancheng Lithium Industry, and Tiancheng Lithium Industry will become a holding subsidiary of the company.
It is reported that Tiancheng Lithium Industry is a production enterprise specializing in refining lithium sulfate solution. In the early stage, the company acquired 33.33% equity of the target company through capital increase and equity transfer, and now it is a shareholding company. The company’s acquisition of part of the equity of the target company will help accelerate the breakthrough of the company’s existing industrial bottleneck, further expand the existing business scope and accelerate the transformation and upgrading. In addition, Tiancheng Lithium Industry’s "10,000 tons lithium carbonate equivalent lithium sulfate solution production line" has been completed, and entered the trial production stage in May, and now it has reached the design capacity.
According to the announcement, the transaction price is 212 million yuan, and the difference between the combined cost of the acquisition and the fair value of the identifiable net assets will be recognized as goodwill, with an estimated amount of about 387 million yuan, which poses the risk of forming a large amount of goodwill.
Taiji Group Levofloxacin and Sodium Chloride Injection Approved to Increase Specifications
Taiji Group announced on the evening of September 6th that Southwest Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received the Notice of Approval for Drug Supplement Application from National Medical Products Administration, agreeing to increase the specifications of its "levofloxacin sodium chloride injection (class 4 of chemicals)" by 50ml: levofloxacin 0.25g and sodium chloride 0.45g, and issued the approval number. It is reported that the company obtained the drug registration certificate in April 2021, and the specifications approved at that time were 100ml: levofloxacin 0.5g and sodium chloride 0.9 g; On June 23 of the same year, the company won the bid for the fifth batch of national centralized collection of this drug.
According to the data, the indications of levofloxacin sodium chloride injection are mainly used to treat the following mild, moderate and severe infections caused by sensitive strains such as Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Enterococcus faecalis or methicillin-sensitive Staphylococcus epidermidis in adults over 18 years old: Hospital-acquired pneumonia; Community acquired pneumonia; Acute bacterial sinusitis; Acute bacterial attack of chronic bronchitis; Complex skin and skin structure infection; Non-complex skin and skin soft tissue infection; Chronic bacterial prostatitis; Complex urinary tract infection; Acute pyelonephritis; Non-complex urinary tract infection; Treatment of inhaled anthrax (after exposure).
This drug is a Class B drug in the Catalogue of National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2020 Edition). Up to now, according to the query of National Medical Products Administration database, there are 6 domestic companies with the production approval documents of this specification, and Southwest Pharmaceutical Co., Ltd. has obtained the production approval documents of this specification for the sixth company. According to the statistics of "Menet" database, in 2021, the total sales volume of levofloxacin sodium chloride injection with 50ml specifications in China city public hospitals was about 10.96 million yuan.
Taiji Group said that according to the relevant national policies, the increased specifications of the drug are consistent with the quality and efficacy of the original drug, and the approval of listing is regarded as a consistent evaluation of the quality and efficacy of generic drugs, which is conducive to enhancing the market competitiveness of the drug.